156 related articles for article (PubMed ID: 26444353)
21. Histopathological indicators of disease outcome in class IV lupus nephritis: a revisit of various indices.
Rathi M; Gupta KL; Joshi K; Gupta PK; Sharma A; Kohli HS; Jha V; Sakhuja V
Rheumatol Int; 2015 Sep; 35(9):1511-7. PubMed ID: 25758229
[TBL] [Abstract][Full Text] [Related]
22. Histopathologic and clinical outcome of rituximab treatment in patients with cyclophosphamide-resistant proliferative lupus nephritis.
Gunnarsson I; Sundelin B; Jónsdóttir T; Jacobson SH; Henriksson EW; van Vollenhoven RF
Arthritis Rheum; 2007 Apr; 56(4):1263-72. PubMed ID: 17393458
[TBL] [Abstract][Full Text] [Related]
23. Analysis of the effectiveness and safety of rituximab in patients with refractory lupus nephritis: a chart review.
Contis A; Vanquaethem H; Truchetet ME; Couzi L; Rigothier C; Richez C; Lazaro E; Duffau P
Clin Rheumatol; 2016 Feb; 35(2):517-22. PubMed ID: 26762196
[TBL] [Abstract][Full Text] [Related]
24. Validation of the Systemic Lupus International Collaborating Clinics classification criteria in a cohort of patients with full house glomerular deposits.
Rijnink EC; Teng YKO; Kraaij T; Dekkers OM; Bruijn JA; Bajema IM
Kidney Int; 2018 Jan; 93(1):214-220. PubMed ID: 28950993
[TBL] [Abstract][Full Text] [Related]
25. Prognostic significance of repeat biopsy in lupus nephritis: Histopathologic worsening and a short time between biopsies is associated with significantly increased risk for end stage renal disease and death.
Arriens C; Chen S; Karp DR; Saxena R; Sambandam K; Chakravarty E; James JA; Merrill JT
Clin Immunol; 2017 Dec; 185():3-9. PubMed ID: 27923701
[TBL] [Abstract][Full Text] [Related]
26. Retrospective analysis of nephritis response and renal outcome in a cohort of 928 Egyptian lupus nephritis patients: a university hospital experience.
Momtaz M; Fayed A; Wadie M; Gamal SM; Ghoniem SA; Sobhy N; Kamal Elden NM; Hamza WM
Lupus; 2017 Dec; 26(14):1564-1570. PubMed ID: 28625079
[TBL] [Abstract][Full Text] [Related]
27. [Feasibility of SLEDAI-2000 and BILAG-2004 scoring systems for assessing renal disease activity in children with lupus nephritis].
Zhou JQ; Jiang H
Zhongguo Dang Dai Er Ke Za Zhi; 2012 Oct; 14(10):775-9. PubMed ID: 23092572
[TBL] [Abstract][Full Text] [Related]
28. Recent Advances in Treatment Strategies for Lupus Nephritis.
Karasawa K; Uchida K; Takabe T; Moriyama T; Nitta K
Contrib Nephrol; 2018; 195():42-50. PubMed ID: 29734149
[TBL] [Abstract][Full Text] [Related]
29. Rituximab treatment in resistant lupus nephritis: A single-center prospective study.
Alam S; Mazumder MA; Sharma M; Mahanta PJ; Parry MA; Doley PK
Clin Nephrol; 2024 Jul; 102():1-7. PubMed ID: 38660888
[TBL] [Abstract][Full Text] [Related]
30. A prospective multicentre study of mycophenolate mofetil combined with prednisolone as induction therapy in 213 patients with active lupus nephritis.
F L; Y T; X P; L W; H W; Z S; H Z; Z H;
Lupus; 2008 Jul; 17(7):622-9. PubMed ID: 18625634
[TBL] [Abstract][Full Text] [Related]
31. The value of early renal biopsy in systemic lupus erythematosus patients presenting with renal involvement.
Hsieh YP; Wen YK; Chen ML
Clin Nephrol; 2012 Jan; 77(1):18-24. PubMed ID: 22185964
[TBL] [Abstract][Full Text] [Related]
32. Clinicopathological findings, treatment response and predictors of long-term outcome in a cohort of lupus nephritis patients managed according to the Euro-lupus regime: a retrospective analysis in Sri Lanka.
Herath N; Ratnatunga N; Weerakoon K; Wazil A; Nanayakkara N
BMC Res Notes; 2017 Feb; 10(1):80. PubMed ID: 28148285
[TBL] [Abstract][Full Text] [Related]
33. Outcome of lupus nephritis in childhood onset SLE in North and Central India: single-centre experience over 25 years.
Srivastava P; Abujam B; Misra R; Lawrence A; Agarwal V; Aggarwal A
Lupus; 2016 Apr; 25(5):547-57. PubMed ID: 26637291
[TBL] [Abstract][Full Text] [Related]
34. Efficacy of rituximab in 164 patients with biopsy-proven lupus nephritis: pooled data from European cohorts.
Díaz-Lagares C; Croca S; Sangle S; Vital EM; Catapano F; Martínez-Berriotxoa A; García-Hernández F; Callejas-Rubio JL; Rascón J; D'Cruz D; Jayne D; Ruiz-Irastorza G; Emery P; Isenberg D; Ramos-Casals M; Khamashta MA;
Autoimmun Rev; 2012 Mar; 11(5):357-64. PubMed ID: 22032879
[TBL] [Abstract][Full Text] [Related]
35. An observational study of outcome in SLE patients with biopsy-verified glomerulonephritis between 1986 and 2004 in a defined area of southern Sweden: the clinical utility of the ACR renal response criteria and predictors for renal outcome.
Nived O; Hallengren CS; Alm P; Jönsen A; Sturfelt G; Bengtsson AA
Scand J Rheumatol; 2013; 42(5):383-9. PubMed ID: 23829689
[TBL] [Abstract][Full Text] [Related]
36. Histological predictors of renal outcome in lupus nephritis: the importance of tubulointerstitial lesions and scoring of glomerular lesions.
Obrișcă B; Jurubiță R; Andronesi A; Sorohan B; Achim C; Bobeica R; Gherghiceanu M; Mandache E; Ismail G
Lupus; 2018 Aug; 27(9):1455-1463. PubMed ID: 29759047
[TBL] [Abstract][Full Text] [Related]
37. [The repeated biopsy in patients with lupus nephritis].
Subils G; Alba P; Gobbi C; Astesana P; Babini A; Albiero E
Rev Fac Cien Med Univ Nac Cordoba; 2014; 71(4):165-70. PubMed ID: 25927882
[TBL] [Abstract][Full Text] [Related]
38. Remission of lupus nephritis: the trajectory of histological response in successfully treated patients.
Malvar A; Alberton V; Lococo B; Lourenco M; Martinez J; Burna L; Besso C; Navarro J; Nagaraja HN; Khatiwada A; Wolf B; Rovin B
Lupus Sci Med; 2023 May; 10(1):. PubMed ID: 37258036
[TBL] [Abstract][Full Text] [Related]
39. Altered expression of signalling lymphocyte activation molecule receptors in T-cells from lupus nephritis patients-a potential biomarker of disease activity.
Stratigou V; Doyle AF; Carlucci F; Stephens L; Foschi V; Castelli M; McKenna N; Cook HT; Lightstone L; Cairns TD; Pickering MC; Botto M
Rheumatology (Oxford); 2017 Jul; 56(7):1206-1216. PubMed ID: 28387859
[TBL] [Abstract][Full Text] [Related]
40. Assessment of long-term remission in lupus nephritis patients: a retrospective analysis over 30 years.
Fernandes das Neves M; Irlapati RV; Isenberg D
Rheumatology (Oxford); 2015 Aug; 54(8):1403-7. PubMed ID: 25725362
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
